20 Mar 2020 by admin in UncategorizedComments Design Therapeutics Launches with $45 Million to Develop a New Class of Disease-Modifying Therapies for Serious Degenerative Disorders
20 Mar 2020 by admin in UncategorizedComments Design Therapeutics Launches with $45 Million to Develop a New Class of Disease-Modifying Therapies for Serious Degenerative Disorders
12 Mar 2020 by admin in UncategorizedComments resTORbio Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
12 Mar 2020 by admin in UncategorizedComments NextCure Reports Fourth Quarter and Full Year 2019 Financial Results
12 Mar 2020 by admin in UncategorizedComments Arcellx Announces FDA Orphan Drug Designation for CART-ddBCMA for the Treatment of Multiple Myeloma
